DUX4 inhibitors (Novogen)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug NameDUX4 inhibitors (Novogen)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDouble homeobox protein 4 inhibitors
TargetsDouble homeobox protein 4
Therapy Area/IndicationsMuscular Dystrophies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKazia Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKazia Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsMuscular Dystrophies

Other Information

ATC CodeN/A
Related LinksN/A